Hypertension induces oxidative stress but not macrophage infiltration in the kidney in the early stage of experimental diabetes mellitus

American Journal of Nephrology

Volumn 26, Issue 5, 2006, Pages 415-422

  Biswas, Subrata K ^a   Lopes De Faria, Jose B ^a  

^a UNIVERSITY OF CAMPINAS   (Brazil)

Author keywords

Diabetic nephropathy; Hypertension; Inflammation; Macrophage; Oxidative stress; Spontaneously hypertensive rats

Indexed keywords

3 NITROTYROSINE; 8 HYDROXYDEOXYGUANOSINE; GLUTATHIONE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD PRESSURE MEASUREMENT; CONTROLLED STUDY; DIABETES MELLITUS; DIABETIC NEPHROPATHY; DIABETOGENESIS; DISEASE MARKER; GLOMERULUS BASEMENT MEMBRANE; HYPERGLYCEMIA; KIDNEY TUBULE BASEMENT MEMBRANE; MACROPHAGE MIGRATION; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN INDUCTION; PROTEIN MODIFICATION; RAT; RENOVASCULAR HYPERTENSION; SPECIES COMPARISON; SPONTANEOUSLY HYPERTENSIVE RAT; STREPTOZOCIN DIABETES; WISTAR KYOTO RAT;

ANIMALS; CELL MOVEMENT; DIABETES MELLITUS, EXPERIMENTAL; DIABETIC NEPHROPATHIES; HYPERTENSION; MACROPHAGES; MALE; OXIDATIVE STRESS; RATS; RATS, INBRED SHR; RATS, INBRED WKY;

EID: 33845811011     PISSN: 02508095     EISSN: None     Source Type: Journal    
DOI: 10.1159/000095707     Document Type: Article

References (26)

1. US Renal Data System: USRDS 2001 Annual Data Report. Bethesda, National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, 2001.
2. Klag MJ, Whelton PK, Randall BL, Neaton JD, Brancati FL, Ford CE: Blood pressure and end-stage renal disease in men. N Engl J Med 1996;334:13-18.
3. Hypertension in Diabetic Study (HDS): I. Prevalence of hypertension in newly presenting type 2 diabetic patients and the association with risk factors for cardiovascular and diabetic complications. J Hypertens 1993;11:309-317.
4. Cooper ME, Allen TJ, O'Brien RC, Macmillan PA, Clarke B, Jerums G: Effects of genetic hypertension on diabetic nephropathy in the rat - functional and structural characteristics. J Hypertens 1988;6:1009-1016.
5. Wolf G: New insights into the pathophysiology of diabetic nephropathy: from haemodynamics to molecular pathology. Eur J Clin Invest 2004;34:785-796.
6. Nishikawa T, Edelstein D, Du XL, Yamagishi S, Matsumura T, Kaneda Y: Normalizing mitochondrial superoxide production blocks three pathways of hyperglycemic damage. Nature 2000;404:787-790.
7. Guzik TJ, Mussa S, Gastaldi D, Sadowski J, Ratnatunga C, Pillai R, Channon KM: Mechanisms of increased vascular superoxide production in human diabetes mellitus: role of NAD(P)H oxidase and endothelial nitric oxide synthase. Circulation 2002;105:1656-1662.
8. Barnes PJ, Karin M: Mechanisms of disease: nuclear factor-κB - a pivotal transcription factor in chronic inflammatory diseases. N Engl J Med 1997;336:1066-1071.
9. Furuta T, Saito T, Ootaka T: The role of macrophages in diabetic glomerulosclerosis. Am J Kidney Dis 1993;21:480-485.
10. Asaba K, Tojo A, Onozato ML, Goto A, Quinn MT, Fujita T: Effects of NADPH oxidase inhibitor in diabetic nephropathy. Kidney Int 2005;67:1890-1898.
11. Utimura R, Fujihara CK, Mattar AL, Malheiros DM, De Lourdes Noronha I, Zatz R: Mycophenolate mofetil prevents the development of glomerular injury in experimental diabetes. Kidney Int 2003;63:209-216.
12. Obrosova IG, Fathallah L, Liu E, Nourooz-Zadeh J: Early oxidative stress in the diabetic kidney: effect of DL-alpha-lipoic acid. Free Radic Biol Med 2003;34:186-195.
13. Ishii N, Patel KP, Lane PH, Taylor T, Bian K, Murad F: Nitric oxide synthesis and oxidative stress in the renal cortex of rats with diabetes mellitus. J Am Soc Nephrol 2001;12:1630-1639.
14. Kakkar R, Mantha SV, Radhi J, Prasad K, Kalra J: Antioxidant defense system in diabetic kidney: a time course study. Life Sci 1997;60:667-679.
15. Young BA, Johnson RJ, Alpers CE, Eng E, Gordon K, Floege J: Cellular events in the evolution of experimental diabetic nephropathy. Kidney Int 1995;47:935-944.
16. Sassy-Prigent C, Heudes D, Mandet C, Belair M, Michel O, Perdereau B: Early glomerular macrophage recruitment in streptozotocin-induced diabetic rats. Diabetes 2000;49:466-475.
17. Kato S, Luyckx VA, Ots M, Lee KW, Ziai F, Troy JL: Renin-angiotensin blockade lowers MCP-1 expression in diabetic rats. Kidney Int 1999;56:1037-1048.
18. Rodriguez-Iturbe B, Quiroz Y, Nava M, Bonet L, Chavez M, Herrera-Acosta J: Reduction of renal immune cell infiltration results in blood pressure control in genetically hypertensive rats. Am J Physiol Renal Physiol 2002;282:F191-F201.
19. Vaziri ND: Roles of oxidative stress and antioxidant therapy in chronic kidney disease and hypertension. Curr Opin Nephrol Hypertens 2004;13:93-99.
20. Pavan MV, Ghini B, Castro M, Lopes De Faria JB: Prevention of hypertension attenuates albuminuria and renal expression of fibronectin in diabetic spontaneously hypertensive rats. Am J Nephrol 2003;23:422-428.
21. Silveira LA, Bacchi CE, Pinto GA, Lopes de Faria JB: The genetics of hypertension modifies the renal cell replication response induced by experimental diabetes. Diabetes 2002;51:1529-1534.
22. Beutler E, Duron O, Mikus B: Improved method for the determination of blood glutathione. J Lab Clin Med 1963;16:882-888.
23. Halliwell B: What nitrates tyrosine? Is nitrotyrosine specific as a biomarker of peroxynitrite formation in vivo? FEBS Lett 1997;411:157-160.
24. Galkina E, Ley K: Leukocyte recruitment and vascular injury in diabetic nephropathy. J Am Soc Nephrol 2006;17:368-377.
25. Sies H: Oxidative Stress: Oxidants and Antioxidants. New York, Academic Press, 1991.
26. Hartner A, Veelken R, Wittmann M, Cordasic N, Hilgers KF: Effects of diabetes and hypertension on macrophage infiltration and matrix expansion in the rat kidney. BMC Nephrol 2005;6:6.